arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Crescent Capital BDC, Inc.

CCAP
$9.76 ▼ -0.06 (-0.61%) at close
24 Visible periods
22 Metrics
Peer-ranked Benchmarks
Price Chart
52
Health
Fair
Bearish
auto_awesome

Analytical Summary

Crescent Capital BDC, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $359.7M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -1.4%
FCF / Share $0.27
Trailing P/E
Price / Book 0.6x
FCF Yield 2.7%
Debt / Equity 1.41
info Valuation on last close. End-of-day price, Sep 22, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-3.25M
↑ +79.1%
FCF / Share Free cash flow per share
$0.27
↑ +141.5%
Long-Term Debt Long-term obligations
$922.95M
↑ +1.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Returns
54
Financial Health
33
Cash Quality
88

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 24 quarters